Status:
COMPLETED
Vasoactive Hormones During the Night in Patients With Obstructive Sleep Apnea and Healthy Controls.
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Healthy
Obstructive Sleep Apnea
Eligibility:
All Genders
20-65 years
Brief Summary
Obstructive sleep apnea syndrome is complicated by considerable cardiovascular morbidity and mortality, at least partly due to hypertension. Nocturnal hypoxia, hypercapnia and acidosis stimulate chemo...
Eligibility Criteria
Inclusion
- Male and female Age 20-65 Obstructive sleep apnea
Exclusion
- Drug or alcohol abuse Pregnancy or breast feeding Cancer Clinical signs or history of disease in the heart, lungs, kidney or endocrine organs Abnormal laboratory tests Albuminuria or glucosuria Aterial hypertension for healthy subjects
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00291993
Start Date
January 1 2004
Last Update
April 21 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical Research, Holstebro Hospital
Holstebro, Ringkoebing County, Denmark, 7500
2
Department of Medical Research
Holstebro, Denmark, 7500
3
Holstebro Hospital, Department of Medical Research
Holstebro, Denmark, 7500